Login to Your Account

Dendreon Restructures: EU Commercial Deal in the Cards?

By Trista Morrison

Monday, September 12, 2011
Shares of Dendreon Corp. – which have plummeted nearly 70 percent in just over a month – edged up 52 cents on Friday in the wake of a restructuring that will eliminate about one-quarter of the biotech's workforce, or roughly 500 employees.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription